Terns Pharmaceuticals
TERN
#4046
Rank
NZ$4.85 B
Marketcap
NZ$53.90
Share price
5.99%
Change (1 day)
378.31%
Change (1 year)

Revenue for Terns Pharmaceuticals (TERN)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Terns Pharmaceuticals from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A-100%
2021 NZ$1.46 M
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA